HEADER TRANSFERASE 14-MAR-18 6CQ0 TITLE TBK1 IN COMPLEX WITH DIMETHYL AMINO ANALOG OF AMLEXANOX COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE TBK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NF-KAPPA-B-ACTIVATING KINASE,T2K,TANK-BINDING KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TBK1, NAK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PH7PFB KEYWDS TBK1, KINASE, AMLEXANOX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.S.BEYETT,J.J.G.TESMER REVDAT 4 04-OCT-23 6CQ0 1 REMARK REVDAT 3 25-DEC-19 6CQ0 1 REMARK REVDAT 2 20-FEB-19 6CQ0 1 REMARK REVDAT 1 05-DEC-18 6CQ0 0 JRNL AUTH T.S.BEYETT,X.GAN,S.M.REILLY,A.V.GOMEZ,L.CHANG,J.J.G.TESMER, JRNL AUTH 2 A.R.SALTIEL,H.D.SHOWALTER JRNL TITL DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF SUBSTITUTED JRNL TITL 2 2-AMINO-5-OXO-5H-CHROMENO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID JRNL TITL 3 DERIVATIVES AS INHIBITORS OF THE INFLAMMATORY KINASES TBK1 JRNL TITL 4 AND IKK EPSILON FOR THE TREATMENT OF OBESITY. JRNL REF BIOORG. MED. CHEM. V. 26 5443 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 30270002 JRNL DOI 10.1016/J.BMC.2018.09.020 REMARK 2 REMARK 2 RESOLUTION. 3.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 15093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 764 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.2141 - 6.8627 0.99 2741 139 0.1795 0.2348 REMARK 3 2 6.8627 - 5.4495 1.00 2767 152 0.2636 0.3471 REMARK 3 3 5.4495 - 4.7614 1.00 2736 147 0.2235 0.2703 REMARK 3 4 4.7614 - 4.3263 1.00 2755 138 0.2130 0.2425 REMARK 3 5 4.3263 - 4.0164 1.00 2768 144 0.2405 0.3102 REMARK 3 6 4.0164 - 3.7797 1.00 2761 146 0.2528 0.2822 REMARK 3 7 3.7797 - 3.5905 1.00 2768 150 0.2929 0.3250 REMARK 3 8 3.5905 - 3.4342 1.00 2728 146 0.3342 0.4042 REMARK 3 9 3.4342 - 3.3021 1.00 2732 141 0.3774 0.4393 REMARK 3 10 3.3021 - 3.1881 0.89 2445 131 0.3939 0.4682 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.620 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.050 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 112.7 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 139.5 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.001 5004 REMARK 3 ANGLE : 0.355 6758 REMARK 3 CHIRALITY : 0.037 750 REMARK 3 PLANARITY : 0.003 858 REMARK 3 DIHEDRAL : 12.133 3012 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 0 THROUGH 369 ) REMARK 3 ORIGIN FOR THE GROUP (A): 93.5538 -21.5958 3.0840 REMARK 3 T TENSOR REMARK 3 T11: 0.7498 T22: 1.0448 REMARK 3 T33: 1.0243 T12: 0.0547 REMARK 3 T13: 0.0032 T23: -0.0330 REMARK 3 L TENSOR REMARK 3 L11: 2.9547 L22: 2.1170 REMARK 3 L33: 1.7345 L12: 0.6740 REMARK 3 L13: -0.7314 L23: 0.3288 REMARK 3 S TENSOR REMARK 3 S11: -0.1163 S12: 0.3440 S13: -0.9426 REMARK 3 S21: -0.0789 S22: -0.2066 S23: -0.2328 REMARK 3 S31: 0.2703 S32: -0.1024 S33: 0.4147 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 370 THROUGH 657 ) REMARK 3 ORIGIN FOR THE GROUP (A): 66.9833 -10.0151 25.2460 REMARK 3 T TENSOR REMARK 3 T11: 0.6662 T22: 1.2969 REMARK 3 T33: 0.7784 T12: -0.0819 REMARK 3 T13: 0.0355 T23: 0.0600 REMARK 3 L TENSOR REMARK 3 L11: 8.5444 L22: 1.0222 REMARK 3 L33: 0.4819 L12: 0.8816 REMARK 3 L13: 2.1365 L23: 0.3204 REMARK 3 S TENSOR REMARK 3 S11: 0.2394 S12: -0.6692 S13: 0.1501 REMARK 3 S21: 0.1450 S22: -0.3160 S23: 0.0690 REMARK 3 S31: 0.1746 S32: -0.1974 S33: 0.0589 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CQ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000233203. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15107 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.190 REMARK 200 RESOLUTION RANGE LOW (A) : 48.209 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 15.73 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 15.38 REMARK 200 R MERGE FOR SHELL (I) : 1.71400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.850 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4IM0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 4% PEG 8000, 10% REMARK 280 DMSO, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.00200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.50100 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 28.50100 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.00200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -2 REMARK 465 ASN A -1 REMARK 465 ASN A 41 REMARK 465 ASN A 42 REMARK 465 ILE A 43 REMARK 465 SER A 44 REMARK 465 PHE A 45 REMARK 465 LEU A 46 REMARK 465 ARG A 47 REMARK 465 PRO A 48 REMARK 465 VAL A 49 REMARK 465 ASP A 50 REMARK 465 ALA A 161 REMARK 465 ARG A 162 REMARK 465 GLU A 163 REMARK 465 LEU A 164 REMARK 465 GLU A 165 REMARK 465 ASP A 166 REMARK 465 ASP A 167 REMARK 465 GLU A 168 REMARK 465 GLN A 169 REMARK 465 PHE A 170 REMARK 465 VAL A 171 REMARK 465 SER A 172 REMARK 465 LEU A 173 REMARK 465 TYR A 174 REMARK 465 ARG A 187 REMARK 465 ALA A 188 REMARK 465 VAL A 189 REMARK 465 LEU A 190 REMARK 465 ARG A 191 REMARK 465 LYS A 192 REMARK 465 ASP A 193 REMARK 465 HIS A 194 REMARK 465 GLN A 195 REMARK 465 LYS A 196 REMARK 465 LYS A 197 REMARK 465 TYR A 198 REMARK 465 GLY A 199 REMARK 465 ALA A 200 REMARK 465 THR A 201 REMARK 465 VAL A 202 REMARK 465 LYS A 480 REMARK 465 VAL A 481 REMARK 465 TYR A 482 REMARK 465 GLU A 483 REMARK 465 LYS A 484 REMARK 465 LEU A 485 REMARK 465 MET A 486 REMARK 465 LYS A 487 REMARK 465 ILE A 488 REMARK 465 ASN A 489 REMARK 465 LEU A 490 REMARK 465 GLU A 491 REMARK 465 ALA A 492 REMARK 465 ALA A 493 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 358 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 15 -82.67 -99.33 REMARK 500 ARG A 134 -62.27 61.31 REMARK 500 THR A 156 -48.95 -145.32 REMARK 500 PHE A 158 69.66 -150.20 REMARK 500 PRO A 223 -164.39 -69.93 REMARK 500 PRO A 227 69.23 -68.34 REMARK 500 ARG A 228 -94.36 -130.28 REMARK 500 ASN A 230 35.93 -80.62 REMARK 500 LYS A 241 75.35 21.68 REMARK 500 SER A 243 -85.67 59.30 REMARK 500 LEU A 532 12.57 -163.92 REMARK 500 GLU A 540 -75.40 -131.83 REMARK 500 GLU A 604 -55.17 -146.91 REMARK 500 TYR A 650 -83.50 -75.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F8M A 801 DBREF 6CQ0 A 1 657 UNP Q9UHD2 TBK1_HUMAN 1 657 SEQADV 6CQ0 SER A -2 UNP Q9UHD2 EXPRESSION TAG SEQADV 6CQ0 ASN A -1 UNP Q9UHD2 EXPRESSION TAG SEQADV 6CQ0 ALA A 0 UNP Q9UHD2 EXPRESSION TAG SEQRES 1 A 660 SER ASN ALA MET GLN SER THR SER ASN HIS LEU TRP LEU SEQRES 2 A 660 LEU SER ASP ILE LEU GLY GLN GLY ALA THR ALA ASN VAL SEQRES 3 A 660 PHE ARG GLY ARG HIS LYS LYS THR GLY ASP LEU PHE ALA SEQRES 4 A 660 ILE LYS VAL PHE ASN ASN ILE SER PHE LEU ARG PRO VAL SEQRES 5 A 660 ASP VAL GLN MET ARG GLU PHE GLU VAL LEU LYS LYS LEU SEQRES 6 A 660 ASN HIS LYS ASN ILE VAL LYS LEU PHE ALA ILE GLU GLU SEQRES 7 A 660 GLU THR THR THR ARG HIS LYS VAL LEU ILE MET GLU PHE SEQRES 8 A 660 CYS PRO CYS GLY SER LEU TYR THR VAL LEU GLU GLU PRO SEQRES 9 A 660 SER ASN ALA TYR GLY LEU PRO GLU SER GLU PHE LEU ILE SEQRES 10 A 660 VAL LEU ARG ASP VAL VAL GLY GLY MET ASN HIS LEU ARG SEQRES 11 A 660 GLU ASN GLY ILE VAL HIS ARG ASP ILE LYS PRO GLY ASN SEQRES 12 A 660 ILE MET ARG VAL ILE GLY GLU ASP GLY GLN SER VAL TYR SEQRES 13 A 660 LYS LEU THR ASP PHE GLY ALA ALA ARG GLU LEU GLU ASP SEQRES 14 A 660 ASP GLU GLN PHE VAL SER LEU TYR GLY THR GLU GLU TYR SEQRES 15 A 660 LEU HIS PRO ASP MET TYR GLU ARG ALA VAL LEU ARG LYS SEQRES 16 A 660 ASP HIS GLN LYS LYS TYR GLY ALA THR VAL ASP LEU TRP SEQRES 17 A 660 SER ILE GLY VAL THR PHE TYR HIS ALA ALA THR GLY SER SEQRES 18 A 660 LEU PRO PHE ARG PRO PHE GLU GLY PRO ARG ARG ASN LYS SEQRES 19 A 660 GLU VAL MET TYR LYS ILE ILE THR GLY LYS PRO SER GLY SEQRES 20 A 660 ALA ILE SER GLY VAL GLN LYS ALA GLU ASN GLY PRO ILE SEQRES 21 A 660 ASP TRP SER GLY ASP MET PRO VAL SER CYS SER LEU SER SEQRES 22 A 660 ARG GLY LEU GLN VAL LEU LEU THR PRO VAL LEU ALA ASN SEQRES 23 A 660 ILE LEU GLU ALA ASP GLN GLU LYS CYS TRP GLY PHE ASP SEQRES 24 A 660 GLN PHE PHE ALA GLU THR SER ASP ILE LEU HIS ARG MET SEQRES 25 A 660 VAL ILE HIS VAL PHE SER LEU GLN GLN MET THR ALA HIS SEQRES 26 A 660 LYS ILE TYR ILE HIS SER TYR ASN THR ALA THR ILE PHE SEQRES 27 A 660 HIS GLU LEU VAL TYR LYS GLN THR LYS ILE ILE SER SER SEQRES 28 A 660 ASN GLN GLU LEU ILE TYR GLU GLY ARG ARG LEU VAL LEU SEQRES 29 A 660 GLU PRO GLY ARG LEU ALA GLN HIS PHE PRO LYS THR THR SEQRES 30 A 660 GLU GLU ASN PRO ILE PHE VAL VAL SER ARG GLU PRO LEU SEQRES 31 A 660 ASN THR ILE GLY LEU ILE TYR GLU LYS ILE SER LEU PRO SEQRES 32 A 660 LYS VAL HIS PRO ARG TYR ASP LEU ASP GLY ASP ALA SER SEQRES 33 A 660 MET ALA LYS ALA ILE THR GLY VAL VAL CYS TYR ALA CYS SEQRES 34 A 660 ARG ILE ALA SER THR LEU LEU LEU TYR GLN GLU LEU MET SEQRES 35 A 660 ARG LYS GLY ILE ARG TRP LEU ILE GLU LEU ILE LYS ASP SEQRES 36 A 660 ASP TYR ASN GLU THR VAL HIS LYS LYS THR GLU VAL VAL SEQRES 37 A 660 ILE THR LEU ASP PHE CYS ILE ARG ASN ILE GLU LYS THR SEQRES 38 A 660 VAL LYS VAL TYR GLU LYS LEU MET LYS ILE ASN LEU GLU SEQRES 39 A 660 ALA ALA GLU LEU GLY GLU ILE SER ASP ILE HIS THR LYS SEQRES 40 A 660 LEU LEU ARG LEU SER SER SER GLN GLY THR ILE GLU THR SEQRES 41 A 660 SER LEU GLN ASP ILE ASP SER ARG LEU SER PRO GLY GLY SEQRES 42 A 660 SER LEU ALA ASP ALA TRP ALA HIS GLN GLU GLY THR HIS SEQRES 43 A 660 PRO LYS ASP ARG ASN VAL GLU LYS LEU GLN VAL LEU LEU SEQRES 44 A 660 ASN CYS MET THR GLU ILE TYR TYR GLN PHE LYS LYS ASP SEQRES 45 A 660 LYS ALA GLU ARG ARG LEU ALA TYR ASN GLU GLU GLN ILE SEQRES 46 A 660 HIS LYS PHE ASP LYS GLN LYS LEU TYR TYR HIS ALA THR SEQRES 47 A 660 LYS ALA MET THR HIS PHE THR ASP GLU CYS VAL LYS LYS SEQRES 48 A 660 TYR GLU ALA PHE LEU ASN LYS SER GLU GLU TRP ILE ARG SEQRES 49 A 660 LYS MET LEU HIS LEU ARG LYS GLN LEU LEU SER LEU THR SEQRES 50 A 660 ASN GLN CYS PHE ASP ILE GLU GLU GLU VAL SER LYS TYR SEQRES 51 A 660 GLN GLU TYR THR ASN GLU LEU GLN GLU THR HET F8M A 801 25 HETNAM F8M 2-AMINO-7-[3-(DIMETHYLAMINO)PROPYL]-5-OXO-5H- HETNAM 2 F8M [1]BENZOPYRANO[2,3-B]PYRIDINE-3-CARBOXYLIC ACID HETSYN F8M 7-[3-(DIMETHYLAMINO)PROPYL] ANALOG OF AMLEXANOX FORMUL 2 F8M C18 H19 N3 O4 HELIX 1 AA1 GLN A 52 LYS A 61 1 10 HELIX 2 AA2 SER A 93 GLU A 99 1 7 HELIX 3 AA3 GLU A 100 ALA A 104 5 5 HELIX 4 AA4 PRO A 108 GLY A 130 1 23 HELIX 5 AA5 HIS A 181 GLU A 186 1 6 HELIX 6 AA6 LEU A 204 GLY A 217 1 14 HELIX 7 AA7 ASN A 230 GLY A 240 1 11 HELIX 8 AA8 SER A 270 ASN A 283 1 14 HELIX 9 AA9 TRP A 293 HIS A 307 1 15 HELIX 10 AB1 THR A 331 LYS A 344 1 14 HELIX 11 AB2 ILE A 346 GLN A 350 5 5 HELIX 12 AB3 LEU A 366 PHE A 370 5 5 HELIX 13 AB4 ASP A 407 VAL A 479 1 73 HELIX 14 AB5 LEU A 495 LEU A 526 1 32 HELIX 15 AB6 ALA A 535 GLU A 540 5 6 HELIX 16 AB7 ARG A 547 GLU A 572 1 26 HELIX 17 AB8 ALA A 576 ASP A 603 1 28 HELIX 18 AB9 GLU A 604 VAL A 644 1 41 HELIX 19 AC1 VAL A 644 GLU A 649 1 6 SHEET 1 AA1 6 MET A 1 SER A 3 0 SHEET 2 AA1 6 HIS A 7 GLN A 17 -1 O TRP A 9 N GLN A 2 SHEET 3 AA1 6 ASN A 22 HIS A 28 -1 O ARG A 25 N ASP A 13 SHEET 4 AA1 6 LEU A 34 VAL A 39 -1 O ILE A 37 N PHE A 24 SHEET 5 AA1 6 LYS A 82 MET A 86 -1 O MET A 86 N ALA A 36 SHEET 6 AA1 6 LEU A 70 GLU A 75 -1 N GLU A 74 O VAL A 83 SHEET 1 AA2 2 ILE A 141 ILE A 145 0 SHEET 2 AA2 2 SER A 151 LEU A 155 -1 O VAL A 152 N VAL A 144 SHEET 1 AA3 3 PHE A 221 ARG A 222 0 SHEET 2 AA3 3 SER A 247 VAL A 249 1 O GLY A 248 N ARG A 222 SHEET 3 AA3 3 ASP A 258 SER A 260 -1 O ASP A 258 N VAL A 249 SHEET 1 AA4 5 THR A 320 HIS A 327 0 SHEET 2 AA4 5 ARG A 308 SER A 315 -1 N SER A 315 O THR A 320 SHEET 3 AA4 5 ILE A 379 VAL A 382 1 O ILE A 379 N HIS A 312 SHEET 4 AA4 5 GLU A 351 TYR A 354 -1 N GLU A 351 O VAL A 382 SHEET 5 AA4 5 ARG A 357 LEU A 359 -1 O ARG A 357 N TYR A 354 SITE 1 AC1 9 LEU A 15 ALA A 36 MET A 86 GLU A 87 SITE 2 AC1 9 PHE A 88 CYS A 89 PRO A 90 MET A 142 SITE 3 AC1 9 THR A 156 CRYST1 134.803 134.803 85.503 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007418 0.004283 0.000000 0.00000 SCALE2 0.000000 0.008566 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011695 0.00000